C B Pratt
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
-
- Sarcoma Diagnosis and Treatment
Papers in
-
- Sarcoma Diagnosis and Treatment 14
-
- Cancer therapeutics and mechanisms 9
- Renal and related cancers 3
- Co-authors
- William H. Meyer (11 shared papers)L. Kun (4 shared papers)Sue C. Kaste (9 shared papers)Gaston K. Rivera (5 shared papers)Marc E. Horowitz (6 shared papers)Clinton F. Stewart (5 shared papers)Craig A. Hurwitz (3 shared papers)M L Hancock (3 shared papers)
- Journals
- Journal of Clinical Oncology (24 papers)American Journal of Roentgenology (3 papers)Journal of Pediatric Surgery (2 papers)Cancer (2 papers)The Gerontologist (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
C B Pratt
65 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 106
- Oncology 723
- Pulmonary and Respiratory Medicine 696
- Neurology 318
- Genetics 228
- Pathology and Forensic Medicine 375
Countries citing papers authored by C B Pratt
This map shows the geographic impact of C B Pratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C B Pratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C B Pratt more than expected).
Fields of papers citing papers by C B Pratt
This network shows the impact of papers produced by C B Pratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C B Pratt. The network helps show where C B Pratt may publish in the future.
Co-authors
The 25 scholars most cited alongside C B Pratt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 255 | |
| 2 | 1998 | 187 | |
| 3 | 1999 | 150 | |
| 4 | 1994 | 116 | |
| 5 | 1994 | 116 | |
| 6 | 1995 | 112 | |
| 7 | 1991 | 103 | |
| 8 | 1986 | 92 | |
| 9 | 1994 | 87 | |
| 10 | 1992 | 79 | |
| 11 | 1994 | 74 | |
| 12 | 1993 | 73 | |
| 13 | 1998 | 69 | |
| 14 | 1991 | 68 | |
| 15 | Phase II trial of ifosfamide in children with malignant solid tumors. | 1987 | 64 |
| 16 | 1996 | 63 | |
| 17 | 1990 | 61 | |
| 18 | 1997 | 60 | |
| 19 | 1995 | 46 | |
| 20 | 2004 | 43 |
About C B Pratt
C B Pratt is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Pathology and Forensic Medicine and Neurology, having authored 65 papers that have together received 2.6k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (14 papers), Neuroblastoma Research and Treatments (9 papers), Cancer therapeutics and mechanisms (9 papers), Chemotherapy-induced organ toxicity mitigation (7 papers), Cancer Treatment and Pharmacology (5 papers), Ocular Oncology and Treatments (4 papers), Renal and related cancers (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). The work is most often cited by research in Oncology (723 citations), Pulmonary and Respiratory Medicine (696 citations), Neurology (318 citations), Genetics (228 citations) and Pathology and Forensic Medicine (375 citations). C B Pratt has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include William H. Meyer, L. Kun, Sue C. Kaste, Gaston K. Rivera, Marc E. Horowitz, Clinton F. Stewart, Craig A. Hurwitz, M L Hancock, Melissa M. Hudson and John F. Kuttesch. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Roentgenology, Journal of Pediatric Surgery, Cancer and The Gerontologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.